Neuronal nicotinic acetylcholine receptor-cholesterol crosstalk in Alzheimer's disease

被引:49
作者
Barrantes, Francisco J. [1 ]
Borroni, Virginia [1 ]
Valles, Sofia [1 ]
机构
[1] UNESCO, Chair Biophys & Mol Neurobiol, Inst Invest Bioquim Bahia Blanca, Bahia Blanca, Buenos Aires, Argentina
关键词
Cholesterol; Acetylcholine receptor; Alzheimer's disease; Synapse; Receptor; Nicotinic; AMYLOID PRECURSOR PROTEIN; E-DERIVED PEPTIDES; APOLIPOPROTEIN-E; A-BETA; LIPID RAFTS; TRANSGENIC MODEL; TAU PATHOLOGY; SH-SY5Y CELLS; MOUSE MODEL; IN-VITRO;
D O I
10.1016/j.febslet.2009.11.036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease (AD) is one of the most devastating diseases of the central nervous system (CNS). It is characterized by two neuropathological findings: amyloid plaques and neurofibrillary tangles. AD is also accompanied by an extensive functional deficit in the cholinergic system, involving the neuronal-type nicotinic acetylcholine receptor (AChR). Furthermore there is increasing evidence showing a misregulation of cholesterol metabolism in the development of the disease. Since cholesterol affects AChR protein at multiple levels, the cognitive impairment and other neurological correlates of AD might be partly associated with an abnormal crosstalk between the receptor protein and the sterol in this synaptopathy. (C) 2009 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:1856 / 1863
页数:8
相关论文
共 90 条
[21]   β-amyloid peptide activates α7 nicotinic acetylcholine receptors expressed in Xenopus oocytes [J].
Dineley, KT ;
Bell, KA ;
Bui, D ;
Sweatt, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (28) :25056-25061
[22]   Apolipoprotein E, amyloid-β, and blood-brain barrier permeability in Alzheimer disease [J].
Donahue, John E. ;
Johanson, Conrad E. .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2008, 67 (04) :261-270
[23]   Deletion of the α7 Nicotinic Acetylcholine Receptor Gene Improves Cognitive Deficits and Synaptic Pathology in a Mouse Model of Alzheimer's Disease [J].
Dziewczapolski, Gustavo ;
Glogowski, Carolina M. ;
Masliah, Eliezer ;
Heinemann, Stephen F. .
JOURNAL OF NEUROSCIENCE, 2009, 29 (27) :8805-8815
[24]   Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function [J].
Fantini, Jacques ;
Barrantes, Francisco J. .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2009, 1788 (11) :2345-2361
[25]   The role of cholesterol in the biosynthesis of β-amyloid. [J].
Frears, ER ;
Stephens, DJ ;
Walters, CE ;
Davies, H ;
Austen, BM .
NEUROREPORT, 1999, 10 (08) :1699-1705
[26]   Apolipoprotein e-derived peptides block α7 neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes [J].
Gay, EA ;
Klein, RC ;
Yakel, JL .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (02) :835-842
[27]   Structural determinates for apolipoprotein E-derived peptide interaction with the α7 nicotinic acetylcholine receptor [J].
Gay, Elaine A. ;
Bienstock, Rachelle J. ;
Lamb, Patricia W. ;
Yakel, Jerrel L. .
MOLECULAR PHARMACOLOGY, 2007, 72 (04) :838-849
[28]   Regulation of cholesterol and sphingomyelin metabolism by amyloid-β and presenilin [J].
Grimm, MOW ;
Grimm, HS ;
Pätzold, AJ ;
Zinser, EG ;
Halonen, R ;
Duering, M ;
Tschäpe, JA ;
De Strooper, B ;
Müller, U ;
Shen, J ;
Hartmann, T .
NATURE CELL BIOLOGY, 2005, 7 (11) :1118-1123
[29]   Behavioral phenotyping of GFAP-ApoE3 and-ApoE4 transgenic mice: ApoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology [J].
Hartman, RE ;
Wozniak, DF ;
Nardi, A ;
Olney, JW ;
Sartorius, L ;
Holtzman, DM .
EXPERIMENTAL NEUROLOGY, 2001, 170 (02) :326-344
[30]   Increased levels of tau protein in SH-SY5Y cells after treatment with cholinesterase inhibitors and nicotinic agonists [J].
Hellström-Lindahl, E ;
Moore, H ;
Nordberg, Y .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (02) :777-784